Jessett Alexander J.

CPT President & CFO Alexander sells 5,627 shares at $109.69; stock now -13.8% from 52-week high after +6.2% 90-day rise

Jessett Alexander J. sold 5,627 shares (3.8% of pre-transaction holdings) at $109.69, reducing his stake to 141,821 shares. The stock has since declined to $108.23, down 13.8% from its 52-week high of $125.53, though it has gained 6.2% over the past 90 days. His prior CPT-specific selling pattern shows two of two measurable trades were well-timed at the 90-day mark (with negative 90d returns of -3.2% and -3.6%), suggesting tactical selling ahead of declines at this ticker. However, this transaction occurs after a recent 90-day rally, and the current price remains well above the transaction price, indicating the 90-day outcome for this particular sale has not yet followed his historical pattern. The company reports strong fundamentals with annual revenue growth of +106.8% and net income of $108,934,000.00, though a high P/E of 42.78 may constrain near-term upside.

President & CFO sold 14,929 shares (10.9% of holdings) for $1,701,166.70 at blended $113.95 amid -33.5% revenue decline

Jessett Alexander J. executed two separate sales totaling 14,929 shares for $1,701,166.70, reducing his stake from 137,313 to 122,384 shares. The transactions occurred at $114.50 on 2025-01-06 and $110.06 on 2025-01-08, bracketing the subsequent price weakness—the current price of $111.04 sits between the two execution prices. Notably, CPT's latest quarter showed negative net income of $-4,204,000 and full-year revenue contraction of -33.5%, while the stock trades at a P/E of 34.38, suggesting elevated valuation amid fundamental deterioration. The insider's cross-ticker track record shows one prior sell with a 100% well-timed rate at the 90-day mark (negative post-sale returns), and his prior trade at CPT on 2024-01-04 exhibited the same pattern: both 30-day and 90-day returns of -1.7% and -2.4% respectively, indicating prior sells preceded declines.